Company Monitoring Page for Allergan

latest headlines for company on cafepharma

Top analyst finds a silver lining in AbbVie’s $63B Allergan buyout — but there’s a catch
Endpoints
Wed, 06/26/19 - 11:51 am
Tags:
AbbVie, Allergan, M&A, R&D, layoffs
Here's Why Nobody's Happy About This $63 Billion Buyout
Motley Fool
Wed, 06/26/19 - 10:41 am
Tags:
AbbVie, Allergan, M&A
How Brent Saunders’ Allergan experiment failed
Stat
Wed, 06/26/19 - 10:12 am
Tags:
Brent Saunders, Allergan, AbbVie, Pharma CEOs
AbbVie’s $63 Billion Mistake
Motley Fool
Tue, 06/25/19 - 07:20 pm
Tags:
AbbVie, Allergan, M&A
AbbVie to acquire Allergan for $63 billion in megamerger of pharma giants
Stat
Tue, 06/25/19 - 09:18 am
Tags:
AbbVie, Allergan, M&A, Humira
Allergan’s Botox Approved for Pediatric Limb Spasticity Amid Split-Up Rumors
Endpoints
Fri, 06/21/19 - 11:48 pm
Tags:
Allergan, FDA, Botox, pediatric, upper limb spasticity
Analyst call with Allergan execs stokes anticipation of a plan to split the company in ‘a month or two’
Endpoints
Thu, 06/20/19 - 10:06 am
Tags:
Allergan
Allergan says 'sense of urgency' could prompt move within 60 days
Biopharma Dive
Wed, 06/19/19 - 10:19 am
Tags:
Allergan
Ironwood, Allergan adds a slate of PhIIIb data to its Linzess pitch for physicians, patients
Endpoints
Wed, 06/19/19 - 09:49 am
Tags:
Ironwood Pharmaceuticals, Allergan, Linzess, clinical trials, IBS-C
Mark Your Calendar For These June PDUFA Dates
Yahoo/Benzinga
Sat, 06/1/19 - 12:52 pm
Tags:
FDA, Merck, Zerbaxa, XERIS, Gvoke HypoPen, Keytruda, Amag Pharmaceuticals, Palatin, Vyleesi, Acer Therapeutics, Edsivo, Sanofi, Regeneron, Dupixent, Alexion, Soliris, Retrophin, Thiola, Allergan, Botox
Allergan puts Vraylar on blockbuster track with new bipolar depression nod
Fierce Pharma
Tue, 05/28/19 - 12:21 pm
Tags:
Allergan, FDA, Vraylar, bipolar disorder
Evolus sparks controversy with Cancun beach bash ahead of Jeuveau launch
Fierce Pharma
Thu, 05/16/19 - 11:43 pm
Tags:
Evolus, Allergan, Jeuveau, drug launches, aesthetics, physicians
Allergan chief Saunders takes a painful $2.5B hit on an ugly PhIII flop
Endpoints
Tue, 05/7/19 - 10:36 am
Tags:
Allergan, Brent Saunders
Breast implants tied to rare cancer to remain on US market
Yahoo/AP
Sat, 05/4/19 - 04:51 pm
Tags:
FDA, breast implants, Allergan
Allergan CEO Saunders hangs on to chairman's title, winning shareholder support — but not by a big enough margin to squelch critics
Endpoints
Wed, 05/1/19 - 12:23 pm
Tags:
Allergan, Pharma CEOs, Brent Saunders
‘Something needs to change’: An Allergan analyst spells out why next week’s vote could still spark a major revamp
Endpoints
Fri, 04/26/19 - 10:27 am
Tags:
Allergan, Brent Saunders, shareholders
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More
Xconomy
Sun, 04/21/19 - 12:16 am
Tags:
FDA, CRISPR, gene therapy, Achaogen, Allergan, Alnylam, Adverum Biotechnologies, Blackstone Life Sciences
Supreme Court sends Allergan packing over Restasis tribal licensing strategy
Fierce Pharma
Mon, 04/15/19 - 11:44 pm
Tags:
Allergan, Supreme Court, Restasis
Influential proxy firms kick back at activists’ demands for Brent Saunders to give up his chairman’s title at Allergan
Endpoints
Mon, 04/15/19 - 10:29 am
Tags:
Allergan, Brent Saunders, activists
Allergan’s failed depression drug shows promise in opioid withdrawal
Fierce Biotech
Sun, 04/7/19 - 05:13 pm
Tags:
Allergan, rapastinel, Naurex, opioids, opioid withdrawal

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.